文献速递神经肿瘤

重新审视世界卫生组织二级脑膜瘤全切除后的辅助放疗

Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma.
PubMed 文献 · World Neurosurg · 2017-04-24

本研究回顾本机构1988至2011年诊断的69例非典型脑膜瘤,比较全切除后观察(61例)与辅助放疗(8例)的预后,并系统综述9项既往研究;结果显示观察组与放疗组在无进展生存和总生存上无显著差异,提示全切除后观察可能是放疗的安全替代。

要点

  • 本机构69例中,观察组61例与放疗组8例的5年无进展生存率分别为79%与88%(P=0.67),无显著差异。
  • 系统综述9项研究显示,观察组与放疗组复发率分别为18%与19%(P=0.9),总生存率分别为84%与93%(P=0.2)。
  • 作者认为全切除后观察可能是不放疗的安全替代方案。

核心结论

  • 非典型脑膜瘤全切除后单纯观察与肿瘤复发风险或死亡率增加无关。
  • 系统综述提示观察可能提供与放疗等效的无进展生存和总生存。
  • 作者认为全切除后观察可能是放疗的安全替代。

研究设计与样本

  • 对本机构1988至2011年诊断的所有非典型脑膜瘤进行病理复习和回顾性病历审查。
  • 纳入69例患者,其中61例接受观察,8例接受放疗。
  • 补充系统文献综述,检索1979年以来比较非典型脑膜瘤全切除后观察与放疗的英文文献,共识别9项既往研究。

主要发现

  • 本机构队列中,观察组15例和放疗组3例出现肿瘤复发,5年无进展生存率分别为79%与88%(P=0.67)。
  • 本机构队列中,观察组19例和放疗组2例死亡,5年总生存率分别为89%与83%(P=0.68)。
  • 系统综述中,观察组与放疗组复发率分别为18%与19%(P=0.9),总生存率分别为84%与93%(P=0.2)。
  • 系统综述中,5年无进展生存率观察组为81%、放疗组为88%(P=0.2),5年生存率观察组为87%、放疗组为96%(P=0.4)。

临床怎么用

  • 作者认为非典型脑膜瘤全切除后观察可能是放疗的安全替代。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Atypical meningioma is a World Health Organization grade II tumor with intermediate prognosis and risk of recurrence. Optimal management after gross total resection (GTR) is controversial, with observation versus adjuvant radiotherapy (RT) contentiously debated. METHODS: Pathologic review was performed of all atypical meningiomas diagnosed at our institution from 1988 to 2011. Retrospective chart review documented patient demographics, extent of surgical resection, history of radiation therapy, progression-free survival (PFS), and overall survival (OS). A supplemental systematic literature review was completed in which English-language articles published since 1979 comparing observation and RT after GTR of atypical meningioma were surveyed. RESULTS: Sixty-nine patients met inclusion criteria. Sixty-one underwent observation, and 8 received RT. Overall, 15 observation and 3 patients undergoing RT experienced tumor recurrence (5-year PFS 79% vs. 88%; P = 0.67); 19 observation and 2 patients undergoing RT died (5-year OS 89% vs. 83%; P = 0.68). Systematic review identified 9 preceding studies reporting extractable data comparing observation and RT outcomes after GTR. Recurrence was 18% and 19% after observation and RT (P = 0.9); total survival was 84% and 93% (P = 0.2). At 5 years, PFS was 81% after observation and 88% after RT (P = 0.2), whereas survival was 87% after observation and 96% after RT (P = 0.4). CONCLUSIONS: Observation alone after GTR of atypical meningioma was not associated with increased risk of tumor recurrence or mortality. Although some preceding authors advocate for RT based on empiric experience, a systematic review also suggests that observation may provide equivalent PFS and OS to RT. Taken together, these findings indicate that observation after GTR may be a safe alternative to RT.

来源:World Neurosurg,查看原文。版权归原作者所有。

引用

  1. Graffeo CS, Leeper HE, Perry A, et al. Revisiting Adjuvant Radiotherapy After Gross Total Resection of World Health Organization Grade II Meningioma. World Neurosurg. 2017. PMID: 28450233. doi:10.1016/j.wneu.2017.04.095

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。